Ophthalmic Viscoelastic Devices Market Updates

Global Ophthalmic Viscoelastic Devices Market size was valued at USD 9.4 Billion in 2023 and is poised to grow from USD 10.42 Billion in 2024 to USD 23.85 Billion by 2032, growing at a CAGR of 10.9% in the forecast period (2025-2032).

Key vendors in Ophthalmic Viscoelastic Devices Market are: 'Rayner Intraocular Lenses Limited', 'Nordic Group B.V.', 'Seikagaku Corporation', 'Alcon Inc.', 'Johnson & Johnson Vision', 'Bausch + Lomb', 'Carl Zeiss Meditec AG', 'BVI Medical', 'Hoya Corporation', 'Carl Zeiss AG', 'Santen Pharmaceutical Co., Ltd.', 'Croma-Pharma GmbH', 'Ophtechnics Unlimited' 

Globally, the incidence of eye-related conditions such as cataracts, glaucoma, and age-related macular degeneration is increasing, largely driven by the aging population and lifestyle factors. These diseases often necessitate surgical interventions where ophthalmic viscoelastic devices are essential to protect the eye’s delicate tissues, maintain space, and facilitate the surgical process. As the number of patients undergoing such procedures grows, so does the demand for high-quality viscoelastic devices, directly fueling market expansion.

Integration of AI and Digital Technologies: Artificial intelligence is increasingly being integrated into ophthalmic surgery workflows, enhancing preoperative planning, intraoperative guidance, and postoperative care. AI-driven imaging and surgical assistance allow for more precise application of viscoelastic devices, minimizing risks and improving surgical outcomes. This technological synergy is leading to higher adoption rates of viscoelastic devices compatible with these advanced systems.

North America is a leading region in the ophthalmic viscoelastic devices market, driven by its advanced healthcare infrastructure and widespread adoption of innovative medical technologies. The high prevalence of eye disorders such as cataracts and glaucoma, combined with increasing awareness about vision care, fuels demand for effective surgical devices. Robust healthcare spending and supportive reimbursement policies further accelerate market growth. The presence of major medical device manufacturers and extensive clinical research also contribute to the strong position of this region.